高海拔2天暴露对肺血管病患者右心室后负荷与氧输送的影响
这项随机对照交叉试验将27例稳定低危肺血管病患者从海拔470米运至2500米并停留2天,发现高海拔暴露使收缩期肺动脉压升高18 mmHg(40%)、总肺阻力升高2.8 WU(32%),右心室动脉耦联指标TAPSE/sPAP比值从0.55降至0.38 mm/mmHg(-31%),尽管氧含量降低但氧输送与低海拔相似。
要点
- 肺血管病患者短期暴露于2500米海拔可显著升高右心室阻力和搏动性后负荷。
- 高海拔暴露降低TAPSE/sPAP比值,提示右心室动脉耦联受损。
- 尽管氧含量下降,整体氧输送仍可维持,部分代偿低氧血症。
核心结论
- 稳定低危肺血管病患者在2500米海拔停留2天可增加右心室后负荷并降低右心室动脉耦联,但氧输送维持不变。
研究设计与样本
- 随机对照交叉试验,纳入27例稳定低危肺血管病患者(44%女性,平均年龄61岁)。
- 患者从海拔470米乘缆车至2500米并停留2天,采用超声心动图评估肺血流动力学,动脉血气测量氧含量。
主要发现
- 高海拔时氧含量较低,但氧输送在两个海拔相似。
关键数值与推荐
- 肺血管病定义为肺动脉高压或慢性血栓栓塞性肺动脉高压。
- 纳入标准为在470米海拔无静息低氧血症的稳定低危患者。
临床怎么用
- 临床医生应告知稳定低危肺血管病患者短期高海拔暴露可能加重右心室后负荷。
- 对于计划前往2500米海拔的肺血管病患者,需评估右心室功能并监测氧输送。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High altitude may adversely affect patients with pulmonary vascular disease (PVD), but acute cardiopulmonary effects remain unclear. RESEARCH QUESTION: How does 2-day high-altitude exposure affect pulmonary hemodynamics and oxygen delivery in patients with PVD defined as pulmonary arterial or chronic thromboembolic pulmonary hypertension? STUDY DESIGN AND METHODS: In this randomized, controlled crossover trial, stable, low-risk patients with PVD without resting hypoxemia at 470 m were transported by cable car to 2,500 m, where they stayed for 2 days. Systolic pulmonary arterial pressure (sPAP), total pulmonary resistance (TPR), right ventricular (RV) arterial coupling, pulmonary arterial elastance (EA), and pulmonary arterial compliance (PAC) were assessed by echocardiography, whereas oxygen content was measured in arterial blood gases. RESULTS: Twenty-seven patients with PVD (44% female; mean [SD] age, 61 [14] years) were included. Altitude exposure was associated with an increase in sPAP of 18 mm Hg (40%; 95% CI, 9-28 mm Hg; P < .001) and TPR of 2.8 Wood units (WU; 32%; 95% CI, 0.7-4.9 WU; P = .007). RV arterial coupling, assessed by tricuspid regurgitation velocity (TAPSE) to sPAP ratio, decreased from a mean (SD) of 0.55 (0.04) mm/mm Hg to 0.38 (0.04) mm/mm Hg (-31%; 95% CI, -0.27 to -0.07 mm/mm Hg; P < .001). EA increased by 0.2 mm Hg/mL (33%; 95% CI, 0.07-0.33 mm Hg/mL; P < .001) and PAC decreased by 1.6 mL/mm Hg (38%; -2.7 to -0.6 mL/mm Hg; P = .002). Although oxygen content was lower at high altitude, oxygen delivery was similar at both altitudes. INTERPRETATION: Our results show that 2-day exposure to 2,500 m in stable, low-risk patients with PVD increases RV resistive and pulsatile afterload and decreases TAPSE to sPAP ratio, indicating reduced RV arterial coupling. Despite attenuated cardiac adaptation, overall function seems to be sufficient to maintain oxygen delivery and to compensate partially for hypoxemia. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05107700; URL: www. CLINICALTRIALS: gov.
引用
- Müller J, Schneider SR, Bauer M, et al. The Effect of a 2-Day Stay at High Altitude (2,500 m) on Right Ventricular Afterload and Oxygen Delivery in Patients With Pulmonary Vascular Disease: A Randomized Controlled Crossover Trial. Chest. 2026. PMID: 42398808. doi:10.1016/j.chest.2026.06.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。